Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$27M Sell
979,000
-179,000
-15% -$3.95M 0.02% 339
2026
Q1
$16.9M Sell
1,158,000
-200,000
-15% -$2.94M 0.02% 406
2025
Q4
$17.2M Sell
1,358,000
-132,000
-9% -$1.95M 0.02% 411
2025
Q3
$22.9M Sell
1,490,000
-52,000
-3% -$838K 0.02% 358
2025
Q2
$24.2M Sell
1,542,000
-54,000
-3% -$819K 0.03% 330
2025
Q1
$30.5M Sell
1,596,000
-1,168,000
-42% -$25.6M 0.04% 281
2024
Q4
$65.9M Sell
2,764,000
-362,000
-12% -$10.1M 0.08% 176
2024
Q3
$87.5M Sell
3,126,000
-153,000
-5% -$4.32M 0.11% 146
2024
Q2
$85.7M Sell
3,279,000
-241,000
-7% -$5.01M 0.11% 140
2024
Q1
$77M Buy
3,520,000
+300,600
+9% +$6.44M 0.11% 152
2023
Q4
$74.9M Buy
3,219,400
+156,400
+5% +$3.15M 0.12% 147
2023
Q3
$60.4M Buy
3,063,000
+294,000
+11% +$5.79M 0.1% 160
2023
Q2
$62.8M Buy
2,769,000
+346,000
+14% +$6.97M 0.11% 160
2023
Q1
$47.6M Buy
2,423,000
+2,173,000
+869% +$41.7M 0.09% 177
2022
Q4
$4.3M Buy
+250,000
New +$4.43M 0.01% 517

Other funds holding RXO

Swedbank's RXO Position: Q2 2026 in Review

Swedbank reduced its RXO (RXO) stake by 15% in Q2 2026, selling an estimated $3.95M and leaving 979,000 shares worth $27M. The position accounts for 0.02% of the portfolio, ranked #339.

Swedbank first reported a position in RXO in Q4 2022 and has held it in 15 quarters since. The position peaked at $87.5M in Q3 2024. 304 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • Swedbank held 979,000 shares of RXO worth $27M as of Q2 2026.
  • Swedbank sold 179,000 RXO shares in Q2 2026, an estimated $3.95M.
  • RXO made up 0.02% of Swedbank's portfolio in Q2 2026, its #339 holding.
  • Swedbank first reported a position in RXO in Q4 2022 and has held it in 15 quarters since.
  • Swedbank's RXO position peaked at $87.5M in Q3 2024.
  • 304 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on Swedbank's 13F filing for Q2 2026, filed 15 Jul 2026.